Retracted: Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target
Dongming Chen(Nanjing Medical University), Xianlin Xu(Nanjing Medical University), Yanhao Shen(Nanjing Medical University), Wei Chen(Shanghai Jiao Tong University), Yi Xiao(The University of Texas Southwestern Medical Center), Meng Zhu(Nanjing Medical University), Changchun Cao(Nanjing Medical University), Yong Xu(Xuzhou Medical College), Shuai Zhu(Nanjing Medical University)
Cited by 75
Related Papers
Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle
|Cancer Research|2021|121
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study
|Cardiovascular Diabetology|2024|104
A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma
|Oncogene|2018|88
Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults
|Cardiovascular Diabetology|2023|85